Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases.

[1]  Sander R. Dubovy,et al.  Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia , 2005, British Journal of Ophthalmology.

[2]  S. Tseng,et al.  Keratolimbal allograft in corneal reconstruction , 2004, Eye.

[3]  A. Solomon,et al.  Long-term effects of mitomycin C in pterygium surgery on scleral thickness and the conjunctival epithelium. , 2002, Ophthalmology.

[4]  G. Rao,et al.  Surgical Treatment of Chronically Recurring Pterygium , 2003, Cornea.

[5]  S. Tseng,et al.  Amniotic membrane transplantation for reconstruction of the conjunctival fornices. , 2003, Ophthalmology.

[6]  S. Daya,et al.  Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. , 2002, Ophthalmology.

[7]  W. Feuer,et al.  Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. , 2002, Ophthalmology.

[8]  M. Grüterich,et al.  Strategien zur Behandlung der Limbusstammzellinsuffizienz , 2002 .

[9]  Y. Tsai,et al.  Acute Scleral Thinning After Pterygium Excision with Intraoperative Mitomycin C: A Case Report of Scleral Dellen After Bare Sclera Technique and Review of the Literature , 2002, Cornea.

[10]  F. González del Valle,et al.  [Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid]. , 2002, Archivos de la Sociedad Espanola de Oftalmologia.

[11]  S. Tseng,et al.  [Surgical approaches for limbal stem cell deficiency]. , 2002, Klinische Monatsblatter fur Augenheilkunde.

[12]  R. T. Pires,et al.  Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. , 2001, Ophthalmology.

[13]  S. Tseng,et al.  Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. , 2001, Archives of ophthalmology.

[14]  K. Tsubota,et al.  Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. , 2000, Ophthalmology.

[15]  S. Tseng,et al.  Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. , 2000, Investigative ophthalmology & visual science.

[16]  E. Holland,et al.  Epithelial stem-cell transplantation for severe ocular-surface disease. , 1999, The New England journal of medicine.

[17]  M. Tso,et al.  Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. , 1998, Ophthalmology.

[18]  A. S. M. Lim,et al.  Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. , 1997, Archives of ophthalmology.

[19]  R. Lindstrom,et al.  Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. , 1996, Cornea.

[20]  Adel Said Elmaghraby,et al.  Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium. , 1996, Ophthalmic surgery and lasers.

[21]  P. Carpineto,et al.  Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. , 1996, The British journal of ophthalmology.

[22]  S. Tseng,et al.  Effect of Stromal Inflammation on the Outcome of Limbal Transplantation for Corneal Surface Reconstruction , 1995, Cornea.

[23]  S. Tseng,et al.  Cytologic evidence of corneal diseases with limbal stem cell deficiency. , 1995, Ophthalmology.

[24]  C. Foster,et al.  Serious complications of topical mitomycin-C after pterygium surgery. , 1992, Ophthalmology.

[25]  S. Crooke,et al.  Mitomycin C. , 1976, IARC monographs on the evaluation of the carcinogenic risk of chemicals to man.